[ET Net News Agency, 15 April 2024] LAEKNA-B (02105) rose 30.8% to HK$6.29, breaking
above the 50-D SMA of HK$5.47.
It hits an intra-day high of HK$6.29, and an intra-day low of HK$4.29, hitting an
1-month low. The total shares traded was 1.75 million, with a value of HK$9.45m. The
active buy/sell ratio is 61:39, with net buying turnover of HK$1.97m. HSBC BROKING SEC
(HK) accounts for greatest net responsive buying turnover of HK$98,400, with volume
weighted average price of HK$6.15. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$455,210, with volume weighted average price of HK$5.378.
Basic Information
=================
---------------------------------
Nominal 6.290 % Chg +30.77%
High 6.290 Low 4.290
Shares Tr 1.75m Turnover 9.45m
10-D SMA 5.404 %H.V 76.135
20-D SMA 6.156 VWAP 5.409
50-D SMA 5.470 RSI14 52.104
---------------------------------
Status: Breaking above the 50-D SMA, hitting an 1-month low, active buy/sell ratio is
61:39, with net buying turnover of HK$1.97m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
LAEKNA-B (02105) 6.29 +30.77
GENSCRIPT BIO (01548) 12.08 -5.33
INNOVENT BIO (01801) 35.85 -4.02
EVEREST MED-B (01952) 24.65 -5.74
WUXI BIO (02269) 13.72 -1.29
TIGERMED (03347) 33.10 +2.64
BEIGENE (06160) 83.20 -2.92
SCICLONE PHARMA (06600) 18.00 +0.22
AKESO (09926) 48.35 -2.32
REMEGEN (09995) 29.50 -8.53
-----------------------------------------------
(ed)